According to Amneal Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $2.39 B. In 2022 the company made a revenue of $2.21 B an increase over the years 2021 revenue that were of $2.09 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $2.39 B | 8.2% |
2022 | $2.21 B | 5.67% |
2021 | $2.09 B | 5.08% |
2020 | $1.99 B | 22.51% |
2019 | $1.62 B | -2.2% |
2018 | $1.66 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.86 B | -63.92% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $0.22 M | -99.99% | ๐บ๐ธ USA |